|
Antiplatelets
Citations 61-70 of 262 total displayed.
|
Past content
(since Jan 1999):
|
- Original Contributions
Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS): A Randomized, Double-Blind, Aspirin-Controlled Trial
- Yukito Shinohara, Katsuya Nishimaru, Tohru Sawada, Akiro Terashi, Shunnosuke Handa, Shunsaku Hirai, Kunihiko Hayashi, Hideo Tohgi, Yasuo Fukuuchi, Shinichiro Uchiyama, Takenori Yamaguchi, Shotai Kobayashi, Kazuoki Kondo, Eiichi Otomo, Fumio Gotoh for the S-ACCESS Study Group
Stroke 2008;39:1827-1833; published online before print as doi:10.1161/STROKEAHA.107.505131
[Abstract]
[Full text]
- Articles
Antiplatelet Therapy in Aneurysmal Subarachnoid Hemorrhage
- Sanne M. Dorhout Mees, Walter M. van den Bergh, Ale Algra, and Gabriel J.E. Rinkel
Stroke published May 8, 2008, doi:10.1161/STROKEAHA.107.509257
[Abstract]
- Emerging Therapies
Antiplatelet Therapy for Secondary Prevention of Noncardioembolic Ischemic Stroke: A Critical Review
- Martin J. ODonnell, Graeme J. Hankey, and John W. Eikelboom
Stroke 2008;39:1638-1646; published online before print as doi:10.1161/STROKEAHA.107.497271
[Abstract]
[Full text]
- Articles
The PREVAIL Trial and Low-Molecular-Weight Heparin for Prevention of Venous Thromboembolism
- Keith W. Muir
Stroke published April 24, 2008, doi:10.1161/STROKEAHA.107.509588
[Abstract]
- Articles
Influence of Socioeconomic Status and Gender on Stroke Treatment and Diagnostics
- Jasmin Arrich, Marcus Müllner, Wolfgang Lalouschek, Stefan Greisenegger, Richard Crevenna, and Harald Herkner
Stroke published April 24, 2008, doi:10.1161/STROKEAHA.107.506147
[Abstract]
- Articles
Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS). A Randomized, Double-Blind, Aspirin-Controlled Trial
- Yukito Shinohara, Katsuya Nishimaru, Tohru Sawada, Akiro Terashi, Shunnosuke Handa, Shunsaku Hirai, Kunihiko Hayashi, Hideo Tohgi, Yasuo Fukuuchi, Shinichiro Uchiyama, Takenori Yamaguchi, Shotai Kobayashi, Kazuoki Kondo, Eiichi Otomo, Fumio Gotoh for the S-ACCESS Study Group
Stroke published April 3, 2008, doi:10.1161/STROKEAHA.107.505131
[Abstract]
- Articles
Dual Antithrombotic Therapy Increases Severe Bleeding Events in Patients With Stroke and Cardiovascular Disease. A Prospective, Multicenter, Observational Study
- Kazunori Toyoda, Masahiro Yasaka, Kazunori Iwade, Ken Nagata, Yukihiro Koretsune, Tomohiro Sakamoto, Shinichiro Uchiyama, Jun Gotoh, Takehiko Nagao, Masahiro Yamamoto, Jun C. Takahashi, Kazuo Minematsu for the Bleeding with Antithrombotic Therapy (BAT) Study Group
Stroke published April 3, 2008, doi:10.1161/STROKEAHA.107.504993
[Abstract]
- Editorials
The Ideal Antiplatelet Drug for Stroke Prevention—Still Elusive
- John W. Norris
Stroke 2008;39:1076-1077; published online before print as doi:10.1161/STROKEAHA.108.515726
[Full text]
- Original Contributions
Trends in Usage of Alternative Antiplatelet Therapy After Stroke and Transient Ischemic Attack
- Nancy K. Hills and S. Claiborne Johnston
Stroke 2008;39:1228-1232; published online before print as doi:10.1161/STROKEAHA.107.496729
[Abstract]
[Full text]
- Original Contributions
Blocking of Platelets or Intrinsic Coagulation Pathway–Driven Thrombosis Does Not Prevent Cerebral Infarctions Induced by Photothrombosis
- Christoph Kleinschnitz, Stefan Braeuninger, Mirko Pham, Madeleine Austinat, Ingo Nölte, Thomas Renné, Bernhard Nieswandt, Martin Bendszus, and Guido Stoll
Stroke 2008;39:1262-1268; published online before print as doi:10.1161/STROKEAHA.107.496448
[Abstract]
[Full text]
|
|